1. Home
  2. CCSI vs MYGN Comparison

CCSI vs MYGN Comparison

Compare CCSI & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consensus Cloud Solutions Inc.

CCSI

Consensus Cloud Solutions Inc.

HOLD

Current Price

$26.45

Market Cap

493.6M

Sector

Technology

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.16

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCSI
MYGN
Founded
2021
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
493.6M
444.2M
IPO Year
2022
1996

Fundamental Metrics

Financial Performance
Metric
CCSI
MYGN
Price
$26.45
$4.16
Analyst Decision
Strong Buy
Buy
Analyst Count
2
7
Target Price
$37.50
$7.64
AVG Volume (30 Days)
81.0K
983.9K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.35
N/A
Revenue
$349,696,000.00
$771,400,000.00
Revenue This Year
$3.33
$6.86
Revenue Next Year
$2.70
$5.45
P/E Ratio
$6.37
N/A
Revenue Growth
N/A
2.33
52 Week Low
$19.24
$3.76
52 Week High
$31.67
$8.59

Technical Indicators

Market Signals
Indicator
CCSI
MYGN
Relative Strength Index (RSI) 49.78 36.06
Support Level $26.42 $3.76
Resistance Level $26.62 $5.52
Average True Range (ATR) 1.22 0.29
MACD 0.10 -0.04
Stochastic Oscillator 39.90 25.32

Price Performance

Historical Comparison
CCSI
MYGN

About CCSI Consensus Cloud Solutions Inc.

Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in the fax cloud business. The company's offerings include communication, data extraction, and digital signature solutions that enable users to securely access, exchange, and manage information across organizational and geographic boundaries. It serves multiple industry verticals, including healthcare, government, financial services, legal, and education. Geographically, the company operates in the United States, Canada, Ireland, and other countries. It derives the maximum revenue from the United States.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: